Bayer Aktiengesellschaft (LON:0P6S)

Market Cap	24.06B
Revenue (ttm)	39.58B
Net Income (ttm)	-2.93B
Shares Out	n/a
EPS (ttm)	-2.98
PE Ratio	n/a
Forward PE	6.03
Dividend	0.09 (0.33%)
Ex-Dividend Date	Apr 28, 2025

Volume	667,959
Average Volume	1,247,751
Open	28.53
Previous Close	28.55
Day's Range	27.94 - 28.54
52-Week Range	18.37 - 31.04
Beta	0.99
RSI	60.75
Earnings Date	Aug 6, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 91,864
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P6S

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR